BioSpace News Archive

Pharm Country

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals, Inc. announces positive top-line safety and efficacy data from its Phase 2 pivotal trial for severe Leukocyte Adhesion Deficiency-I at the 25th Annual Meeting of the American Society of Gene and Cell Therapy.

May 19, 2022
·
8 min read
Pharm Country

Henry Schein Announces Participation in William Blair Emerging Technologies in Dental Care Virtual Investor Conference

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced that the Company presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022.

May 19, 2022
·
2 min read
Biotech Beach

Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines

Be Biopharma, Inc. and National Resilience, Inc. announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline.

May 19, 2022
·
4 min read
Global Smart Healthcare Market Growth Rate of 16.2 % over the Forecast Period [2020-2027]

The latest business intelligence studies predict that the global smart healthcare market will expand at a stellar compound annual growth rate of 16.2 % over the forecast period of 2020 to 2027.

May 19, 2022
·
8 min read
Global Pharmacy Benefit Manager (PBM) Market Insights: Size | Shares | Trends | Industry Analysis [2020-2030]

The interest for pharmacy benefit management is on the ascent attributable to increment in the quantity of protection suppliers with in-house pharmacy benefit groups to oversee secured populace.

May 19, 2022
·
9 min read
Addex Announces Participation in the H.C. Wainwright Global Investment Conference

Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that CEO, Tim Dyer, will be virtually attending the H.C. Wainwright Global Investment Conference taking place May 23 - 26, 2022.

May 19, 2022
·
3 min read
Omicron triples Canada’s COVID-19 infection count, study shows

Nearly 30 per cent of Canadian adults – 9 million people – were infected during the Omicron variant wave early in 2022, compared with just 10 per cent who had been infected in the previous four waves, according to a new study led by Toronto researchers.

May 19, 2022
·
7 min read
Genetown

CENTOGENE to Present at the H.C. Wainwright Global Investment Conference

Centogene N.V. announced that Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022, and invites investors to participate via virtual one-on-one meetings.

May 19, 2022
·
4 min read
Pharm Country

Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)Will expand patient access to BPH treatment

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has received National Medical Products Administration (NMPA) approval for its UroLift ® System in China for treating benign prostatic hyperplasia (BPH).

May 19, 2022
·
4 min read
Biotech Bay

Invitae Launches Expanded Pharmacogenomics Panel and Specialized Mental Health Panel

Invitae announced the commercial availability of the expanded Invitae Pharmacogenomics Panel which includes the specialized Invitae Pharmacogenomics Mental Health Panel and access to a clinical decision support tool.

May 19, 2022
·
7 min read